胰岛素降解酶抗体

胰岛素降解酶抗体产品标准

浓缩液(1mg/1ml) 亲和纯化抗体

产品应用

WB=1:100-500 Elisa =1:200-1000 IP=1:20-100 IHC=1:100-500 （石蜡切片需做抗原修复）

胰岛素降解酶抗体产品说明

Insulysin was identified nearly a century ago as an enzyme responsible for the degradation of insulin in cells, although the precise interactions between insulin and insulysin remain elusive. Human insulysin was cloned in 1988, and shown to be a 118 kDa protein that exists primarily as a homodimer, and perhaps also complexed with other molecules. The sequence is well conserved between humans, rats and mice, and the antibody recognizes these species. Insulysin is a metalloproteinase of the clan ME, family M16, which contains an active site HxxEH, a reversal of the canonical HExxH zinc binding motif. Considered a zinc metalloproteinase, the activity of insulysin can be blocked with EDTA or 1-10 phenanthroline. In addition to the active metalloproteinase domain, insulysin contains a second metalloproteinase site which is considered catalytically inactive, and is thought to assist in substrate binding. Insulysin is most closely related to the bacterial proteinase pitrilysin, (the human orthologue of which appears to be MPRP1) and the mammalian proteinsae nardilysin. Generally thought to be a cytoplasmic protein, insulysin has been isolated from many different tissues and cell lines, and can degrade intact insulin, insulin B chain, glucagon, denatured hemoglobin, alpha amyloid protein, TGF alpha and amylin. Recent work implicates insulysin in clearing beta amyloid plaques from the brain, and has generated much interest in Alzheimer’s disease research. The pH optimum for insulysin is basic, pH 8.5, which also distinguishes it from other metalloproteinases.
Insulin degrading enzyme (IDE) has a preferential affinity for insulin such that the presence of insulin will inhibit IDE mediated degradation of other substrates. IDE degrades a variety of other peptides including atrial natriuretic peptide and amylin. IDE catabolizes A beta and has been implicated as a candidate enzyme responsible for the degradation and clearance of A beta in the brain. IDE has also been shown to degrade the APP intracellular domain (AICD), a product of gamma secretase cleaved APP that may function in nuclear signaling.
mol wt:117kDa
Other Aliases:
Insulin degradation enzyme; FLJ35968; insulin protease; insulinase; insulysin

胰岛素降解酶抗体其它产品：yb-13624R AHNAK神经细胞分化相关蛋白AHNAK抗体
yb-13713R AJAP1粘合连接相关蛋白1抗体
yb-13736R ADAM13去整合素样金属蛋白酶13抗体
yb-10219R Agrin聚集蛋白抗体
yb-12480R AP2 alpha + beta转录因子AP2α+β抗体
yb-12481R phospho-APC (Ser2054)磷酸化腺瘤样息肉抗体
yb-12482R phospho-APC1 (Ser688)磷酸化细胞周期末期促进复合蛋白APC1抗体
yb-12483R APC10细胞周期后期促进蛋白亚基10抗体
yb-12484R APC11细胞周期后期促进蛋白亚基11抗体
yb-12485R APC2腺瘤性结肠息肉病蛋白2抗体
yb-12486R phospho-APC6 (Thr580)磷酸化细胞分裂周期蛋白16抗体
yb-12489R APLFDNA修复酶相互作用蛋白抗体
yb-12490R APMAP脂肪细胞膜相关蛋白抗体
yb-12491R APOA1BP/AI-BP载脂蛋白A1结合蛋白抗体抗体
yb-12492R APOBEC1载脂蛋白B-mRNA编辑酶复合物1抗体
yb-12493R APOBEC2载脂蛋白B-mRNA编辑酶复合物2抗体
yb-12494R APOBEC3B载脂蛋白B-mRNA编辑酶复合物3B抗体
yb-12495R APOBEC3C载脂蛋白B-mRNA编辑酶复合物3C抗体
yb-12496R Apolipoprotein CI/APOC1载脂蛋白C1抗体
yb-12497R Apolipoprotein CII/APOC2载脂蛋白C2抗体
yb-12498R APOL1载脂蛋白L1抗体
yb-12499R APOL4载脂蛋白L4抗体
yb-12500R APOL5载脂蛋白L5抗体
yb-12501R ApoM载脂蛋白M抗体
yb-12502R Apolipoprotein O载脂蛋白O抗体
yb-12503R APPBP1β淀粉样蛋白前体蛋白结合蛋白1抗体
yb-12504R Aprataxin共济失调性眼球运动功能丧失相关蛋白AOA1抗体
yb-12505R APRG1三号染色体开放阅读框抗体
yb-12506R APRT腺嘌呤磷酸核糖转移酶抗体
yb-12507R phospho-AQP2 (Ser256)磷酸化水通道蛋白2抗体
yb-12508R ARF1ADP核糖基化因子1抗体
yb-12510R ARA9乙型肝炎病毒X相关蛋白2抗体
yb-12511R ARF5ADP核糖基化因子5抗体